Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
16 studies found for:    Open Studies | "Restless Legs Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Restless Legs Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Pramipexole;   Drug: Placebo
2 Recruiting A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: MMF07 Foot Massager;   Device: Heat Therapy
3 Not yet recruiting Vitamin D in the Treatment of Primary Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Vitamin D
4 Recruiting An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Interventions: Drug: HORIZANT 300 mg;   Drug: HORIZANT 600 mg;   Drug: Placebo
5 Recruiting An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Intervention: Drug: HORIZANT 600 mg
6 Recruiting A Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Intervention: Drug: HORIZANT 300 mg
7 Not yet recruiting Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Gabapentin Enacarbil (GEn);   Drug: Placebo
8 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
Intervention:
9 Not yet recruiting Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Condition: Restless Legs Syndrome (RLS)
Interventions: Drug: Injectafer® (Ferric Carboxymaltose - FCM);   Drug: Placebo (Normal Saline)
10 Recruiting The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
Condition: Restless Legs Syndrome
Intervention: Drug: Horizant
11 Not yet recruiting Analysis of Sympathetic Activity in Willis-Ekbom Disease
Conditions: Willis-Ekbom Disease;   Restless Legs Syndrome
Intervention: Other: Sympathetic nervous activity measurement
12 Recruiting Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
Conditions: Restless Legs Syndrome;   Iron Deficiency Anemia
Interventions: Drug: Ferumoxytol intravenous;   Drug: Ferrous sulfate
13 Recruiting Specified Drug Use-Results Survey of Regnite
Condition: Restless Legs Syndrome
Intervention: Drug: Regnite
14 Recruiting Infra-slow Oscillations During Sleep
Conditions: Healthy Subjects;   Restless Legs Syndrome;   Periodic Limb Movements During Sleep
Intervention: Other: Acute sleep deprivation
15 Recruiting Sleep Deficiency and Stroke Outcome
Conditions: Sleep Apnea Syndromes;   Sleep Initiation and Maintenance Disorders;   Insomnia;   Restless Legs Syndrome;   Stroke
Intervention:
16 Not yet recruiting Quality Improvement and Practice Based Research in Neurology Using the EMR
Conditions: Brain Tumors;   Epilepsy;   Migraine;   Mild Cognitive Impairment;   Concussion;   Multiple Sclerosis;   Neuropathy;   Parkinson's;   Restless Legs Syndrome;   Stroke
Intervention: Drug: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)

Study has passed its completion date and status has not been verified in more than two years.